Table 1.

Demographic and baseline clinical data. Data shown are expressed as mean ± SD. Data are compared by chi-square test or 1-way ANOVA.

CharacteristicsActive Renal DiseaseActive But No Renal DiseaseRenal Disease in RemissionNeither Active Nor Renal DiseaseControls
No. patients2730253020
Sex, female:male23:426:421:427:315:5
Age, yrs37.2 ± 7.636.8 ± 8.237.8 ± 9.538.2 ± 6.536.4 ± 8.2
Serum albumin, g/dl21.0 ± 5.7**37.3 ± 6.738.2 ± 7.236.8 ± 5.940.2 ± 8.2
Serum creatinine, μmol/l85.5 ± 27.287.2 ± 23.491.3 ± 30.286.4 ± 28.590.3 ± 32.6
Estimated GFR, ml/min97.8 ± 22103 ± 33.593.7 ± 26.193.0 ± 22.695.1 ± 21.5
Proteinuria, g/day2.80 ± 1.60**0 ± 00.52 ± 0.330 ± 00 ± 0
Anti-dsDNA titer432.1 ± 310.6**173.9 ± 102.1#187.4 ± 192.1$43.2 ± 32.70
C3 g/l0.57 ± 0.470.70 ± 0.510.62 ± 0.470.87 ± 0.371.42 ± 0.41
C4 g/l0.14 ± 0.110.13 ± 0.100.13 ± 0.090.16 ± 0.120.19 ± 0.10
SLEDAI score13.1 ± 4.2*10 ± 2.7##2.05 ± 1.00 ± 0
Renal activity score7.4 ± 3.7**0 ± 00 ± 00 ± 0
  • ** p < 0.0001 for Active Renal Disease vs Active But No Renal Disease, Renal Disease in Remission, Neither Active Nor Renal Disease, and controls;

  • * p < 0.0001 for Active Renal Disease vs Renal Disease in Remission, Neither Active Nor Renal Disease, and controls;

  • ## p < 0.0001 for Active But No Renal Disease vs Renal Disease in Remission, Neither Active Nor Renal Disease, and controls;

  • # p < 0.0001 for Active But No Renal Disease versus Neither Active Nor Renal Disease and controls;

  • $ p < 0.0001 for Renal Disease in Remission vs Neither Active Nor Renal Disease and controls,

  • p < 0.001 for controls versus Active Renal Disease, Active But No Renal Disease, Renal Disease in Remission, Neither Active Nor Renal Disease. GFR: glomerular filtration rate; Active Renal Disease: patients with active SLE and renal involvement; Active But No Renal Disease: patients with active SLE but no renal involvement; Renal Disease in Remission: patients with history of lupus nephritis in remission; Neither Active Nor Renal Disease: patients without systemic disease activity and with no history of renal disease; SLE: systemic lupus erythematosus; C3: complement factor 3; SLEDAI: SLE Disease Activity Index.